GenFleet Therapeutics Announces Broad-spectrum Activity of GFH547, an Oral panRAS (ON) Inhibitor, and Its Potential to Overcome Resistance against SIIP-based KRAS Inhibitors in Late-breaking Research Abstract of 2024 AACR Annual Meeting

SHANGHAI and SAN DIEGO, April 9, 2024 /PRNewswire/ — GenFleet Therapeutics, a…

LyondellBasell demonstrates progress toward industry leadership in 2023 sustainability report

HOUSTON and ROTTERDAM, Netherlands, April 9, 2024 /PRNewswire/ — LyondellBasell (NYSE: LYB)…

Texas Cardiac Arrhythmia Institute at St. David's Medical Center first in U.S. to use FDA-approved pulsed field ablation system

AUSTIN, Texas, April 9, 2024 /PRNewswire/ — Electrophysiologists at the Texas Cardiac…

EUR Zero Fees Fiesta: Bybit's Global Campaign Offers Zero Deposit and Trading Fees

DUBAI, UAE, April 9, 2024 /PRNewswire/ — Bybit, one of the world’s top…

GESKE German Beauty Tech Debuts its First-Ever Star-Studded Global Campaign

The global campaign features top celebrities and influencers from around the world,…

Metalpha and Algos Electronics Jointly Set up NOWLIT Fintech Solutions

The strategic partnership will further the Company’s business expansion in North America…

Fiscal Year 2023: Exyte experiences strong growth in Europe and the USA

Sales double in the USA, order intake increases by over 150 percent…

Unipart announces financial results for the year ended 31 December 2023

Unipart delivers strong growth and revenues exceed £1bnProfits recovered well following a…